Continuum Advisory’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-55,105
Closed -$3.32M 961
2025
Q1
$3.32M Sell
55,105
-874
-2% -$54.3K 0.43% 54
2024
Q4
$3.27M Buy
55,979
+291
+0.5% +$17.3K 0.42% 55
2024
Q3
$3.31M Sell
55,688
-12
-0% -$685 0.42% 51
2024
Q2
$3.12M Buy
55,700
+193
+0.3% +$10.8K 0.45% 48
2024
Q1
$3.1M Sell
55,507
-9,042
-14% -$511K 0.46% 45
2023
Q4
$3.48M Buy
+64,549
New +$3.15M 0.5% 37

Other funds holding IHI

Continuum Advisory's IHI Position: Q2 2025 in Review

Continuum Advisory sold out of iShares US Medical Devices ETF (IHI) in Q2 2025, closing a stake of 55,105 shares — an estimated $3.32M sold.

Continuum Advisory first reported a position in IHI in Q4 2023 and held it in 6 quarters. The position peaked at $3.48M in Q4 2023. 546 funds tracked by Wall St. Rank hold IHI as of Q2 2025.

  • Continuum Advisory reported no remaining iShares US Medical Devices ETF position as of Q2 2025 after selling out during the quarter.
  • Continuum Advisory sold 55,105 iShares US Medical Devices ETF shares in Q2 2025, an estimated $3.32M.
  • Continuum Advisory first reported a position in iShares US Medical Devices ETF in Q4 2023 and held it in 6 quarters.
  • Continuum Advisory's iShares US Medical Devices ETF position peaked at $3.48M in Q4 2023.
  • 546 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.